Analyst Price Targets — A
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 14, 2026 10:41 am | Luke Sergott | Barclays | $140.00 | $117.52 | TheFly | Agilent price target lowered to $140 from $150 at Barclays |
| March 9, 2026 1:27 pm | — | Fermium Research | $150.00 | $114.21 | StreetInsider | BofA Securities Reiterates Neutral Rating on Agilent (A) following Biocare Medical acquisition announcement |
| January 20, 2026 9:55 am | — | HSBC | $180.00 | $139.64 | TheFly | Agilent initiated with a Buy at HSBC |
| January 5, 2026 11:18 am | — | Evercore ISI | $160.00 | $137.95 | TheFly | Agilent upgraded to Outperform from In Line at Evercore ISI |
| December 9, 2025 9:28 am | — | Goldman Sachs | $170.00 | $142.44 | TheFly | Agilent initiated with a Buy at Goldman Sachs |
| December 2, 2025 9:27 pm | — | Morgan Stanley | $180.00 | $148.81 | TheFly | Agilent initiated with an Overweight at Morgan Stanley |
| December 1, 2025 9:24 pm | — | Morgan Stanley | $270.00 | $150.10 | TheFly | Agilent initiated with an Overweight at Morgan Stanley |
| November 25, 2025 4:20 pm | Daniel Arias | Stifel Nicolaus | $170.00 | $158.23 | StreetInsider | Agilent (A) PT Raised to $170 at Stifel |
| November 25, 2025 12:18 pm | — | UBS | $180.00 | $153.60 | TheFly | Agilent price target raised to $180 from $170 at UBS |
| November 25, 2025 12:15 pm | Catherine Ramsey Schulte | Robert W. Baird | $165.00 | $153.60 | TheFly | Agilent price target raised to $165 from $142 at Baird |
Latest News for A
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational…
Assetmark Inc. increased its holdings in Agilent Technologies, Inc. (NYSE: A) by 5.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 234,275 shares of the medical research company's stock after buying an additional 12,984 shares during the period. Assetmark
CCLA Investment Management grew its holdings in shares of Agilent Technologies, Inc. (NYSE: A) by 1.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,047,488 shares of the medical research company's stock after purchasing an additional 19,518 shares
Agilent Technologies, Inc. (NYSE: A - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the sixteen research firms that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to
Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in Agilent Technologies, Inc. (NYSE: A) by 288.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,463 shares of the medical research company's stock after acquiring an additional 9,258
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.